{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T20:58:39Z","timestamp":1768251519448,"version":"3.49.0"},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T00:00:00Z","timestamp":1605571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Fondo de Investigaciones Sanitarias"},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI16\/00837 - PI16\/00678"],"award-info":[{"award-number":["PI16\/00837 - PI16\/00678"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fondo de Investigaciones Sanitarias","award":["CM17\/00064"],"award-info":[{"award-number":["CM17\/00064"]}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["JR15\/00031"],"award-info":[{"award-number":["JR15\/00031"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"PFIS fellowship"},{"name":"Fondo de Investigaciones Sanitarias","award":["FI17\/00194"],"award-info":[{"award-number":["FI17\/00194"]}]},{"name":"Fondo de Investigaciones Sanitarias","award":["CM19\/00059"],"award-info":[{"award-number":["CM19\/00059"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,2,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>In the ART-PRO pilot trial there were no virological failures through 48\u2009weeks of treatment with dolutegravir plus lamivudine in suppressed individuals with and without archived lamivudine resistance-associated mutations (RAMs) detected through next-generation sequencing (NGS) but without evidence of lamivudine RAMs in baseline proviral DNA population sequencing.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To present 96\u2009week results from ART-PRO.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Open-label, single-arm pilot trial. At baseline, all participants switched to dolutegravir plus lamivudine. Participants were excluded if proviral DNA population genotyping detected lamivudine RAMs. To detect resistance minority variants, proviral DNA NGS was retrospectively performed from baseline samples. For this analysis the efficacy endpoint was the proportion of participants with &amp;lt;50 HIV-1 RNA copies\/mL at week 96. Safety and tolerability outcomes were incidence of adverse events and treatment discontinuations.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Forty-one participants were included, 21 with lamivudine RAMs in historical plasma RNA genotypes. Baseline proviral DNA NGS detected lamivudine RAMs (M184V\/I and\/or K65R\/E\/N) above a 5% threshold in 71.4% (15\/21) and 15% (3\/20) of participants with and without history of lamivudine resistance, respectively. At 96\u2009weeks, 90.2% of participants achieved the efficacy endpoint. Between week 48 and 96 there was one discontinuation due to consent withdrawal and no discontinuations related to adverse events. Two participants had a transient viral rebound, both re-suppressed on dolutegravir plus lamivudine. Through week 96, there were no virological failures.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>In this pilot trial, dolutegravir plus lamivudine maintained virological suppression at 96\u2009weeks despite historical lamivudine resistance and persisting archived minority lamivudine RAMs.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jac\/dkaa479","type":"journal-article","created":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T20:12:05Z","timestamp":1604002325000},"page":"738-742","source":"Crossref","is-referenced-by-count":29,"title":["Long-term efficacy of dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: Week 96 results of ART-PRO pilot study"],"prefix":"10.1093","volume":"76","author":[{"given":"David","family":"Rial-Crestelo","sequence":"first","affiliation":[{"name":"Hospital Universitario, 12 de Octubre - Imas12, Av. de C\u00f3rdoba, s\/n, 28041 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"de Miguel","sequence":"additional","affiliation":[{"name":"Hospital Universitario La Paz \u2013 IdiPAZ, Paseo de la Castellana 261 28046, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roc\u00edo","family":"Montejano","sequence":"additional","affiliation":[{"name":"Hospital Universitario La Paz \u2013 IdiPAZ, Paseo de la Castellana 261 28046, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lourdes","family":"Dominguez-Dominguez","sequence":"additional","affiliation":[{"name":"Hospital Universitario, 12 de Octubre - Imas12, Av. de C\u00f3rdoba, s\/n, 28041 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Aranguren-Rivas","sequence":"additional","affiliation":[{"name":"Hospital Universitario, 12 de Octubre - Imas12, Av. de C\u00f3rdoba, s\/n, 28041 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9s","family":"Esteban-Cantos","sequence":"additional","affiliation":[{"name":"Hospital Universitario La Paz \u2013 IdiPAZ, Paseo de la Castellana 261 28046, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Otilia","family":"Bisbal","sequence":"additional","affiliation":[{"name":"Hospital Universitario, 12 de Octubre - Imas12, Av. de C\u00f3rdoba, s\/n, 28041 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mireia","family":"Santacreu-Guerrero","sequence":"additional","affiliation":[{"name":"Hospital Universitario, 12 de Octubre - Imas12, Av. de C\u00f3rdoba, s\/n, 28041 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00f3nica","family":"Garcia-Alvarez","sequence":"additional","affiliation":[{"name":"Hospital Universitario, 12 de Octubre - Imas12, Av. de C\u00f3rdoba, s\/n, 28041 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9571-6471","authenticated-orcid":false,"given":"Bel\u00e9n","family":"Alejos","sequence":"additional","affiliation":[{"name":"Instituto de Salud Carlos III, Av. de Monforte de Lemos, 5, 28029 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asunci\u00f3n","family":"Hernando","sequence":"additional","affiliation":[{"name":"Universidad Europea de Madrid- Imas12, Calle Tajo, s\/n, 28670 Villaviciosa de Od\u00f3n, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Bermejo-Plaza","sequence":"additional","affiliation":[{"name":"Hospital Universitario, 12 de Octubre - Imas12, Av. de C\u00f3rdoba, s\/n, 28041 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julen","family":"Cadi\u00f1anos","sequence":"additional","affiliation":[{"name":"Hospital Universitario La Paz \u2013 IdiPAZ, Paseo de la Castellana 261 28046, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Mayoral","sequence":"additional","affiliation":[{"name":"Hospital Universitario La Paz \u2013 IdiPAZ, Paseo de la Castellana 261 28046, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Miguel","family":"Castro","sequence":"additional","affiliation":[{"name":"Hospital Universitario La Paz \u2013 IdiPAZ, Paseo de la Castellana 261 28046, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Moreno","sequence":"additional","affiliation":[{"name":"Hospital Universitario La Paz \u2013 IdiPAZ, Paseo de la Castellana 261 28046, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luz","family":"Martin-Carbonero","sequence":"additional","affiliation":[{"name":"Hospital Universitario La Paz \u2013 IdiPAZ, Paseo de la Castellana 261 28046, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6912-4736","authenticated-orcid":false,"given":"Rafael","family":"Delgado","sequence":"additional","affiliation":[{"name":"Hospital Universitario, 12 de Octubre - Imas12, Av. de C\u00f3rdoba, s\/n, 28041 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Rubio","sequence":"additional","affiliation":[{"name":"Hospital Universitario, 12 de Octubre - Imas12, Av. de C\u00f3rdoba, s\/n, 28041 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Pulido","sequence":"additional","affiliation":[{"name":"Hospital Universitario, 12 de Octubre - Imas12, Av. de C\u00f3rdoba, s\/n, 28041 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7410-9450","authenticated-orcid":false,"given":"Jos\u00e9 Ram\u00f3n","family":"Arribas","sequence":"additional","affiliation":[{"name":"Hospital Universitario La Paz \u2013 IdiPAZ, Paseo de la Castellana 261 28046, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"ART-PRO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J R","family":"Arribas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R De Miguel","family":"Buckley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Montejano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Esteban-Cantos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Stella-Ascariz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Cadi\u00f1anos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Mayoral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J M","family":"Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Martin-Carbonero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Valencia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I","family":"Bernardino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Busca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Mic\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I","family":"P\u00e9rez-Valero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ML","family":"Montes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J Rodr\u00edguez","family":"Centeno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"PI16\/00837-PI16\/00678 study group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Pulido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Rial-Crestelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Dominguez-Dominguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Aranguren-Rivas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O","family":"Bisbal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L Bermejo","family":"Plaza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Garcia-Alvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Santacreu-Guerrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"de Lagarde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Matarranz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Luzckoviak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Sotillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Rubio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,11,17]]},"reference":[{"key":"2021021208581877700_dkaa479-B1","volume-title":"Switching to DTG\/3TC fixed-dose combination (FDC) is non-inferior to continuing a TAF-based regimen (TBR) in maintaining virologic suppression through 96 weeks (TANGO study)","author":"1. Van Wyk","year":"2020"},{"key":"2021021208581877700_dkaa479-B2","doi-asserted-by":"crossref","first-page":"105893","DOI":"10.1016\/j.ijantimicag.2020.105893","article-title":"Retrospective study on the outcomes of two-drugs regimens based on dolutegravir plus one reverse transcriptase inhibitor in virologically suppressed, HIV-Infected Patients","volume":"55","author":"2. Galizzi","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"2021021208581877700_dkaa479-B3","doi-asserted-by":"crossref","first-page":"102779","DOI":"10.1016\/j.ebiom.2020.102779","article-title":"Dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: 48-week results of a non-randomized, pilot clinical trial (ART-PRO)","volume":"55","author":"De Miguel","year":"2020","journal-title":"EBioMedicine"},{"key":"2021021208581877700_dkaa479-B4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ofid\/ofy113","article-title":"Impact of the M184V resistance mutation on virological efficacy and durability of lamivudine-based dual antiretroviral regimens as maintenance therapy in individuals with suppressed HIV-1 RNA: a cohort study","volume":"5","author":"Gagliardini","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"2021021208581877700_dkaa479-B5","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1093\/jac\/dkz009","article-title":"Virological efficacy of dual therapy with lamivudine and dolutegravir in HIV-1-infected virologically suppressed patients: long-term data from clinical practice","volume":"74","author":"Baldin","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"2021021208581877700_dkaa479-B6","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1093\/jac\/dkx233","article-title":"HIV-1 DNA ultra-deep sequencing analysis at initiation of the dual therapy dolutegravir lamivudine in the maintenance DOLULAM pilot study","volume":"72","author":"Charpentier","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"2021021208581877700_dkaa479-B7","author":"7. Reynes","year":"2017"},{"key":"2021021208581877700_dkaa479-B8","author":"Reynes","year":"2020"},{"key":"2021021208581877700_dkaa479-B9","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.12688\/f1000research.15995.1","article-title":"Virologic failure and HIV drug resistance on simplified, dolutegravir-based maintenance therapy: Systematic review and meta-analysis","volume":"7","author":"Wandeler","year":"2018","journal-title":"F1000Res"},{"key":"2021021208581877700_dkaa479-B10","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1093\/cid\/ciy1132","article-title":"Dolutegravir monotherapy versus Dolutegravir\/Abacavir\/Lamivudine for virologically suppressed people living with chronic human immunodeficiency virus infection: the randomized Noninferiority MONotherapy of TiviCAY trial","volume":"69","author":"Hocqueloux","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2021021208581877700_dkaa479-B11","doi-asserted-by":"crossref","first-page":"e547","DOI":"10.1016\/S2352-3018(17)30152-2","article-title":"Dolutegravir as maintenance monotherapy for HIV (DOMONO): a phase 2, randomised non-inferiority trial","volume":"4","author":"Wijting","year":"2017","journal-title":"Lancet HIV"},{"key":"2021021208581877700_dkaa479-B12","first-page":"2267","article-title":"The M184I\/V and K65R nucleoside resistance mutations in HIV-1 prevent the emergence of resistance mutations against dolutegravir","author":"Oliveira","year":"2016"},{"key":"2021021208581877700_dkaa479-B13","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1586\/14787210.2.1.147","article-title":"The impact of the M184V substitution on drug resistance and viral fitness","volume":"2","author":"Wainberg","year":"2004","journal-title":"Expert Rev anti Infect Ther"},{"key":"2021021208581877700_dkaa479-B14","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1086\/430709","article-title":"Antiviral activity of lamivudine in salvage therapy for multidrug-resistant HIV-1 infection","volume":"41","author":"Campbell","year":"2005","journal-title":"Clin Infect Dis"},{"key":"2021021208581877700_dkaa479-B15","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.cell.2013.09.020","article-title":"Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure","volume":"155","author":"Ho","year":"2013","journal-title":"Cell"},{"key":"2021021208581877700_dkaa479-B16","year":"2019"},{"key":"2021021208581877700_dkaa479-B17","year":"2019"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/76\/3\/738\/36241159\/dkaa479.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/76\/3\/738\/36241159\/dkaa479.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,13]],"date-time":"2021-02-13T00:22:26Z","timestamp":1613175746000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/76\/3\/738\/5983891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,17]]},"references-count":17,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,11,17]]},"published-print":{"date-parts":[[2021,2,11]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkaa479","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,3,1]]},"published":{"date-parts":[[2020,11,17]]}}}